BIOLOGY.DIGITAL
Tahoe Therapeutics Releases Tahoe-100M Single-Cell Perturbation Atlas to Train Virtual Cell Models

Image: BioSpace

Launch

Tahoe Therapeutics Releases Tahoe-100M Single-Cell Perturbation Atlas to Train Virtual Cell Models

November 11, 2026 • Source: BioSpace

Tahoe Therapeutics (formerly Vevo Therapeutics) released Tahoe-100M, the world's largest single-cell transcriptomic perturbation dataset comprising 100 million cells across 50 cancer models and 1,100 small-molecule drugs.

**Executive Summary (2026-11-11):** Tahoe Therapeutics (formerly Vevo Therapeutics) released Tahoe-100M, the world's largest single-cell transcriptomic perturbation dataset comprising 100 million cells across 50 cancer models and 1,100 small-molecule drugs. Source: BioSpace.

Technical Architecture & R&D Impact

Generated using its Mosaic in vivo and high-throughput single-cell barcoding platform, Tahoe-100M provides 50x more perturbation training data than prior public Perturb-seq compendia to train predictive virtual cell foundation models.

Enterprise Biopharma Procurement Takeaways

For computational biology leads, medicinal chemists, and R&D IT architects, this milestone underscores the rapid convergence of wet-lab experimental validation and scalable cloud foundation models during H2 2026. Teams evaluating vendors in the Launch category should benchmark API reproducibility, GxP audit readiness, and zero-data-retention VPC deployment terms.

Related Products

Published November 11, 2026

More News

Last updated: November 11, 2026

Ask AI